The Patent Finder

Use of Glucocorticoid Receptor Antagonists in Combination with Glucocorticoids to Treat Adrenal Insufficiency

Corcept Therapeutics Incorporated

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2016/024981, filed Mar 30, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,610,534Use of Glucocorticoid Receptor Antagonists in Combination with Glucocorticoids to Treat Adrenal Insufficiency
In force
 · High confidence
UsedRemaining
Corcept Therapeutics, Inc.In forceHigh confidence
US 11,202,784Use of Glucocorticoid Receptor Antagonists in Combination with Glucocorticoids to Treat Adrenal Insufficiency
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 11,890,289Use of Glucocorticoid Receptor Antagonists in Combination with Glucocorticoids to Treat Adrenal Insufficiency
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 12,691,127Use of Glucocorticoid Receptor Antagonists in Combination with Glucocorticoids to Treat Adrenal Insufficiency
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited